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Interest in endophytes as natural sources for new medicines was inspired by the discovery of paclitaxel-producing 
endophytic fungi. This study investigated the anti-cancer activity of extracts of endophytes isolated from two 
Australian plants, Eremophila longifolia (EL) and Eremophila maculata (EM).  Endophytes were isolated from 
surface-sterilised leaf tissue, grown as pure cultures and identified by sequencing of ITS regions of the ribosomal 
DNA. To determine cytotoxicity, two leukaemic (MOLT-4, T-cell leukaemia; PreB-697, Pre-B leukaemia), a lung 
cancer cell line (A549) and a normal humans fibroblast cell line were treated with endophyte extracts to assess 
cytotoxicity in relation to alternariol monomethyl ether (AME) and alternariol (AOH). Endophyte extracts that 
showed cell cytotoxicity were analysed by UV HPLC to determine the metabolites. Pure AME and AOH, three 
extracts form Alternaria sp. (EM-6, EM-7 and EM-9) and one from Preussia minima sp. (EL-14) were cytotoxic 
to the cancer cell lines. All cytotoxic endophytes contained AME and AOH, the most cytotoxic endophyte EM-6 
also contained two unique peaks. These data indicate that these four endophyte extracts may have anti-cancer 
properties due to the presence of AME and AOH, however the unique compounds found in the EM-6 extract may 
be exclusively cytotoxic and warrant further investigation. 
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Introduction 
The discovery of effective anti-cancer agents from plants can be guided by the use of relevant plants in traditional 
medicine. Some of the first plant-derived natural products introduced into modern day clinical practice were the 
alkaloids, vinblastine and vincristine, isolated from the Madagascar periwinkle, Catharanthus roseus (L.) G. Don. 
(Guéritte and Fahy, 2005). In spite of major investment in the development of new synthetic anti-cancer agents, 
the number of novel chemical compounds is declining and, as a consequence, there is now a systematic search for 
organisms, compounds and genes from the environment that might have potential biotechnological benefit as well 
as leading to new product development. Indeed, in the area of cancer, of the 175 small molecules identified 
between the 1940s to the end of 2014, 131 (75%) are other than “S” (synthetic), with 85 (49%) being either natural 
products or directly derived from them (Cragg and Newman, 2013, Newman and Cragg, 2016). 
A more recent development is the investigation of endophytes as a potential natural source of drugs 





pathogenic with some endophytic fungi isolated from plants found to produce important anti-cancer agents. Some 
of the most significant include Taxol (Stierle et al., 1993, Kharwar et al., 2014), camptothecin (Amna et al., 2006, 
Shweta et al., 2010), vinblastine (Okouneva et al., 2003), vincristine (Yang et al., 2003), Cercosporamide (Wang 
et al., 2012) and alternariol (Singh et al., 2014). Alternariol (AOH) is a toxic metabolite and one of the major 
secondary metabolites produced by various species of Alternaria. It is an important contaminant in cereals and 
fruits and also exhibits antifungal and phytotoxic activity which is reported to inhibit cholinesterase enzymes 
(Singh et al., 2014).The discovery and isolation of such metabolites should allow the development of processes 
to increase their production providing, of course, that the gene/gene product controlling their production by the 
relevant endophytes can be identified (Cragg et al., 2009). 
  The overall aim of this study was to determine if endophytes comprising a collection isolated from two 
native Australian plant species, Eremophila longifolia (EL) and Eremophila maculata (EM) (Zaferanloo et al., 
2013), demonstrated cytotoxic activity on human cancer and normal fibroblast cell lines. Cytotoxicity of 
endophyte extracts and pure alternariol monomethyl ether (AME) and alternariol (AOH)  (Fehr et al., 2009) was 
assessed using two human leukaemic cell lines, MOLT-4 and Pre-B 697, one lung cancer; A549 and a human 
fibroblast cell line. Active extracts were tested for the presence of known cytotoxic components.  
   
Material and Methods 
Isolation and identification of endophytes 
Frozen leaves of E. longifolia and E. maculata were obtained from Canopus Corporation (Byrock, NSW, Australia) 
and a native plant nursery in Horsham (Victoria, Australia), respectively.  The samples were isolated from surface-
sterilised leaf tissue as described by Strobel and Daisy (2003) and grown as pure endophytic cultures on potato 
dextrose agar (PDA) plates for 5 days of growth at 25 ˚C. Extraction of fungal DNA was carried out using the ZR 
Fungal/Bacterial DNA kit (Zymo Research Corp). After assessing the quantity and quality of the extracted DNA, 
amplification and direct sequencing of fungal ITS regions were performed. The ITS1, 5.8S and ITS2 regions of 
the fungal DNA were amplified by PCR using the BioMix Red PCR kit (Bioline). The reaction mixture consisted 
of 10 µmol of each primer ITS1 (5’-TCC GAT GGT GAA CCT GCG G-3’) and ITS4 (5’-TCC TCC GCT TAT 
TGA TAT GC-3’). The purified PCR products were sequenced and analysed using BLASTN software available 
at the National Center of Biotechnology Information (NCBI) web site (http://www.ncbi.nlm.nih.gov/ 
blast/Blast.cgi) to determine the identity of the endophytes (Huang et al., 2009, Zaferanloo et al., 2013).  
 
Comparison of the ITS regions of endophytic fungi 
To reveal evolutionary relationships between isolates, DNA sequences were aligned using CLUSTALW (http:// 
www.ebi.ac.uk/clustalw/) as described by (Zaferanloo et al. (2013)). The phylogenetic relationships of the isolates 
were evaluated using neighbour-joining analysis in MEGA version 5 (Tamura et al., 2011) with a bootstrap value 
obtained from 1000 replicates. Evolutionary distances were computed using the Kimura 2-parameter method 








Preparation of endophyte extracts  
All fungal isolates were grown in Potato Dextrose Broth (PDB) and then filtered by membrane filtration through 
a 0.22 μm filter (Millipore) under vacuum to separate mycelium from broth (Xu et al., 2008). Each sterilized broth 
was frozen in autoclaved round-bottom flask for freeze-drying. The weight of the lyophilized extract was 
measured by first weighing the empty round-bottom flask before adding the filtrate and again after freeze-drying. 
The weight of the freeze-dried compound was calculated by the difference between the two weights and recorded. 
After freeze-drying, the lyophilized powder was mixed in sterile water to the same concentration (100 mg /mL) 
for all samples, kept at 4 °C and used to determine cytotoxic activity. 
  For cell cytotoxicity assays, 10 mg of each individual aqueous endophyte extract, alternariol monomethyl 
ether (AME) or alternariol (AOH), was in dissolved in 1 mL of Phosphate Buffered Saline (PBS) filtered through 
a 0.2μm Nalgene syringe filter (Thermo Scientific) and diluted to required concentrations in RPMI 1640 medium 
supplemented with 10% foetal calf serum (culture medium). 
 
Cell culture and cytotoxicity assays 
All cell lines were grown in RPMI 1640 medium supplemented with 10% foetal calf serum at 37 ⁰ C, 5% C02.
For cytotoxicity assays, PreB697 and MOLT-4 suspension cells were seeded into 96-well plates at densities of 
1.4 x 106/mL and adherent A549 lung cancer and primary fibroblast cells were seeded at densities of 1.5x104/mL 
and 3.5 x105/mL, respectively, and incubated overnight before addition of endophyte extract serially diluted to 
final concentrations ranging from 250.0 to 0.11 μg/mL, or serial dilutions of AME or AOH. Cells were then 
incubated for 72 hours (approximately three cell doublings to ensure detection of response) and cytotoxicity was 
assessed using the colorimetric CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay (Promega) 
(MTS) following the manufacturer’s protocol and absorbance measured at 490 nm. 
  MOLT4 and A549 human cell lines were purchased from American Type Culture Collection (ATCC); 
MOLT4 cells were derived from a patient with acute lymphoblastic leukaemia, and A549 cells were  derived from 
a lung adenocarcinoma. . PreB-697 cells were purchased from Deutsche Sammlung von Mikroorganismen und 




Those endophyte extracts that showed substantial cytotoxicity  (>70% cell death at the highest concentration) in 
any of the cell lines were screened using UV-HPLC for the presence of AME and AOH (Fehr et al., 2009) and 
any other metabolites. AME and AOH standards were initially made to 1 mg/mL in methanol and further diluted 
to 10 μg/ mL in 50 %acetonitrile: 50% of 5% trifluoroacetic acid (TFA) in MilliQ water (w/w) (mobile phase) 
prior to injection. Endophyte extracts of those that elicited significant cytotoxicity >70%; EM6, EM7 and EM9 
and EL-14 were prepared at a concentration of 10 mg/mL in methanol filtered using a 0.2μm Nalgene syringe 
filter (Thermo Scientific) and then diluted, to 1.25 mg/ mL, in 50% MeCN: %0% of 5% TFA prior to injection  
  Ten microliters of each sample was injected at a flow rate of 0.5mL/min, using a Symmetry C18 3.5 µm 
4.6 x 150mm column with security guard C18 4mm x 2mm pre-column (Phenomenex) at room temperature. The 





minutes; linear gradient to 85% mobile phase B (100% acetonitrile) between 3 and 12 minutes, with re-
equilibration at 13 minutes. All analyses were performed on a Waters Alliance HPLC with detection by UV at 
254nm (Fehr et al., 2009). 
 
Statistical Analysis 
For cell cytotoxicity assays, absorbance values were calculated and corrected for wells containing culture medium, 
no-extract controls and for blank wells containing PBS only. The percentage of growth inhibition was analysed 
with R , using the package drc (Ritz and Streibig, 2005) to fit 4 parameter logistic curves to the data with parameter 
values for the gradient, upper and lower asymptote and the EC50 , representing the endophyte extract concentration 
for half maximal inhibition. Analysis of variance was used to compare models fitting separate curves for each 
experiment with a single curve fitted to the combined data for each endophyte extract/cell line combination. Where 
separate curves needed to be fitted to the data, the mean EC50 value was the mean of the three curves (Table 2). 
   
 
Results 
Isolation and identification of the endophytic fungi 
Seventeen isolates of endophytic fungi obtained from the leaves of E. longifolia (EL-1 – EL-17) were previously 
identified and described by Zaferanloo et al. (2013). The ITS regions of the ribosomal DNA from nine additional 
endophytic fungi isolated from E. maculata (EM-1 – EM-9) were amplified by PCR and sequenced. A BLASTN 
search of sequences available in the NCBI database yielded the identity of the isolates (Table 1). Morphological 
analyses supported identification obtained from the NCBI sequence data. Since the DNA sequences displayed 
significant similarities, it was suspected that the fungal isolates were evolutionarily close relatives and 
phylogenetic analysis was performed using DNA rather than protein sequences, and is summarised in Fig. 1, 
where bootstrap scores over 50 indicated that the sequences shared significant homology.  
 
Cytotoxicity of endophyte extracts  
The lyophilized preparations of all 26 endophyte fermentation broths were screened for anticancer/cytotoxicity 
activity. Three different human cancer cell lines (A549 (lung carcinoma); MOLT-4 (T-acute lymphoblastic 
leukaemia), PreB697 (PreB leukaemia) and a fibroblast cell line were incubated for three doubling-times with 
increasing concentrations of fungal endophyte extracts or pure AME or AOH. The Alternaria sp. extract, EM-6, 
was the most cytotoxic against MOLT-4 (EC50 6.41 μg/mL) (Fig. 2A), whereas EM-7 and EM-9 were the most 
cytotoxic against PreB 697 (EC50 39.7 μg/mL and 37.9 μg/mL respectively), (Fig. 2B and 2C). The only Preussia 
sp. endophyte extract that caused any cytotoxicity was EL-14: EC50 116.0 μg/mL for MOLT4 and 42.10 μg/mL 
for PreB697 and 18.10 μg/mL for A549 (Fig. 2D). In all cancer cell lines, pure AOH or AME were substantially 
more toxic than the endophyte extracts (Fig. 3A and 3B). With respect to the normal fibroblast cells, only EM-6 







UV-HPLC of cytotoxic endophyte extracts  
To determine if the endophyte extracts contained AME or AOH and/or any novel metabolites, pure samples of 
AME, AOH and endophytic extracts were analysed using UV-HPLC. Chromatographic traces of endophytes were 
compared to pure AME and AOH traces for relative amounts of AME and AOH within each endophyte, but no 
specific quantification of AME or AOH within the extracts was attempted. 
Retention times (RT) of AOH and AME were 11.2 and 13.9 minutes, respectively (Fig. 5). All cytotoxic extracts 
derived from Alternaria sp., EM-6, EM-7 and EM-9, had peaks corresponding to AME and AOH RT at varying 
area under the curve (AUC) concentrations whereas no such peaks were identified in the Preussia sp. Extract, EL-
14 (Fig. 5). Three extra unique peaks were identified in EM6, two of which were also detected in the EL-14 




Endophytes from E. longifolia were successfully isolated and identified by Zaferanloo et al. (2013). Fourteen 
isolates were identified as belonging to eight different genera, including Alternaria, Cladosporium, Fusarium, 
Leptosphaerulina, Nigrospora, Phoma, Preussia and Stemphylium. These species have previously been identified 
as being endophytic to several plants (Márquez et al., 2012). The genera of the fungal isolates from E. maculata 
were obtained by sequencing of the ITS regions and were identified by a database search in GenBank with a match 
of at least 98% (E=0) (Table 1). 
 
Isolate EM-1 was identified as a coelomycete, Phoma sp.  Phoma spp. have previously been isolated and reported 
as fungal endophytes, with a high abundance in the roots and surrounding soil (Huang et al., 2009, Rodriguez et 
al., 2009, Chandra, 2012). Isolates EM-2 and EM-3 were identified as Stemphylium sp.  Although this endophyte 
is not commonly cited in the literature, some studies demonstrated its ability to produce exopolysaccharide 
(Banerjee et al., 2009, Kharwar et al., 2011).  EM-4 was identified as Preussia sp., a  fungus previously reported 
as an endophyte (Kruys and Wedin, 2009). Isolate EM-5 was identified as Chaetomium sp. which has been 
frequently identified as a fungal endophyte with anticancer activity (Kharwar et al., 2011).  Isolates EM-6, -7, -8 
and -9 were identified as belonging to the genus Alternaria and shared significant homology.  Alternaria spp. 
have been reported as known endophytes with antitumor activity in the native Australian plant, Gossypium (Wang 
et al., 2007, Chen et al., 2016); these plants are known to grow throughout similar regions of Australia where E. 
maculata is found. Notably, in this study, identification of the fungal isolates was performed by searching for 
matches in GenBank. It has been noted that identification based on this method relies on previous sequencing 
results deposited in the database to be accurate and taxonomic groups identified correctly (Bellemain et al., 2010).  
Furthermore, the non-coding ITS regions are subject to rapid evolutionary change, which creates additional 
difficulties in obtaining sequence matches and performing accurate sequence alignments (Huang et al., 2009). 
Thus, in this study, traditional morphological identification techniques were also used to support the molecular 
identification (Huang et al., 2009). It is further recommended that a range of different primers be used to amplify 
the ITS regions and analysing these alongside each other to generate a consensus as this would allow for more 





high percentage of similarity (Table 1) (Fig. 1), there is overall confidence in the identified genera. It is possible 
that other slow growing endophytes were not cultured from the plant samples and consequently did not undergo 
identification (Huang et al., 2009). Some fungi may not be cultivable on laboratory culture media and require 
conditions provided through an obligate host-symbiont relationship; these isolates may be identified by PCR 
analysis of total plant tissue derived DNA (Aly et al., 2011). 
  
AME was not very toxic to the cell lines used in this study. Conversely, AOH had greater toxicity, particularly 
with respect to the MOLT4 and preB leukaemic cells. Of all the endophyte extracts tested, the most toxic was 
EM6 which appeared to have less AME and AOH than the other extracts but also had two unique peaks observed 
in the chromatograph (RT of 9.1 and 10.8 min.) and one peak at RT 14.5 min that was also present in EL-14. 
These extra metabolites may account for the increased toxicity of the EM6 extract towards MOLT4 and preB cells 
compared to the other endophyte extracts; however this would need further investigation. It was perhaps not 
surprising that AME and AOH were cytotoxic to these cancer cell lines to varying degrees but less toxic to the 
fibroblast cell line as they have previously been shown to be cytotoxic to other cancer cell lines  (Aly et al., 2008). 
  The search for new anti-cancer agents continues as the number of affected people will continue to rise 
with increasing longevity. The discovery of new agents will improve the chances of prolonging life and curing 
more cancers. This study has demonstrated that Australian native plants are an untapped source of endophytic 
fungi that produce potentially useful medicinal compounds when cultured in the laboratory in the absence of the 
host plant. This will make it possible to produce medically-relevant metabolites without environmental impacts 
on plant populations and facilitate commercial production. Further work on these endophytic extracts is now 
required to identify and characterise the metabolites with anticancer potential and the development of methods  to 
make such metabolites in commercial quantities is an important consideration.  
 
Our team declare no conflict of interest in this study. 
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Closest Species (accession number) Identity 
(%) 
Sequence 
length   (bp) 
EL-1  Phomamoricola(GQ352491.1) 98  545 
EL-2 Leptosphaerulinaamericana(AY278318.1) 99 537 
EL-3 Stemphylium sp. (EF104168.1) 100 456 
EL-4 Nigrospora sp. (FJ785429.1) 99 483 
EL-5 Leptosphaerulinatrifolii(AY831558.1) 99 538 
EL-6 Cladosporium sp. (GU214631.1) 100 648 
EL-7 Unclassified fungus (EU816402.1)  96  540 
EL-8 Phomaherbarum(AB470824.1)   99 542 
EL-9 Phoma sp. (AY210335.1) 98 493 
EL-10 Fusarium sp. (DQ993637.1)  100 514 
EL-11 Leptosphaerulina sp. (EF694653.1) 99 618 
EL-12 Alternaria sp. (GQ302684.1) 99 570 
EL-13 Unclassified fungus (EF419981.1)    97 574 
EL-14 Preussia minima (DQ468035.1)   95 474 
EL-15 Alternaria sp. (GU187964.1) 100 607 
EL-16 Unclassified fungus (Ef420002.1) 97 544 
EL-17  Alternaria alternata (FJ375168.1) 100 506 
EM-1 Phoma sp. (GQ352491) 98 545 
EM-2 Stemphylium sp. (EF104156) 100 554 
EM-3 Stemphylium sp. (EF076750) 100 500 
EM-4 Preussia sp. (HQ130664) 99 482 
EM-5 Chaetomium sp. (GU934507) 99 519 
EM-6 Alternaria sp. (HQ914864) 99 524 
EM-7 Alternaria sp. (HQ914865) 100 522 
EM-8 Alternaria sp. (HQ914850) 99 522 
EM-9 Alternaria sp. (HQ914865) 99 519 
¹Sequences have been submitted to the GenBank database and assigned the accession numbers JQ316434– 







Table 2:  IC50 values (μg/ml; standard errors in parentheses) for Alternariol (AOH), alternariol 
methyl ester (AME) and extracts EL14, EM6, EM7 and EM9 from the cytotoxicity curves. Data were 
derived from the mean of three experiments (except n=1 for fibroblasts); ud, IC50 undefined due to 
lack of statistical significance (not significantly different from 0). 
 
 
AME AOH EL14 EM6 EM7 EM9 
Molt4 ud 19.10 (1.90) 116.00 (32.2) 6.41 (1.97) 61.60 (3.62) 21.20 (1.95) 
       
A549 ud 76.50 (25.5) ud 35.40 (11.0) 89.70 (50.4) 132.00 (23.9) 
       
preB 27.00 (7.88) 39.40 (7.02) 42.10 (14.3) 4.28 (0.89) 39.70 (10.3) ud 
       
Fibro ud ud ud 46.60 (25.0) ud ud 













Figure 1: The ITS regions of fungal endophytes were used to construct a phylogenetic tree of 
the isolates obtained. The Neighbour-Joining method was used to infer phylogeny using 
MEGA version 5; p-distance and a bootstrapping score of 1000 with values of greater than 
50 % were employed parameters. Significant homology that suggests these isolates could 




 EL-15 Alternaria sp.
 EL-12 Alternaria sp.
 EL-17 Alternaria alternata
 EM-6 Alternaria sp.
 EM-9 Alternaria sp.
 EM-7 Alternaria sp.
 EM-8 Alternaria sp.
 EM-3 Stemphylium sp.
 EM-2 Stemphylium sp.
 EL-3 Stemphylium sp.
 EL-16 Unclassified fungus
 EL-13 Unclassified fungus
 EL-5 Leptosphaerulina trifolii
 EL-2 Leptosphaerulina americana
 EL-9 Phoma sp.
 EL-8 Phoma herbarum
 EM-1 Phoma sp.
 EL-1 Phoma moricola
 EL-11 Leptosphaerulina sp.
 EM-4 Preussia sp.
 EL-14 Preussia minima
 EL-6 Cladosporium sp.
 EM-5 Chaetomium sp.
 EL-7 Unclassified fungus
 EL-4 Nigrospora sp.
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Figure 2: Human cancer cell line cytotoxicity MOLT-4▪, PreB697• and A549 ◊ to endophytes A) EM-6 , 
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Figure 3: Human cancer cell line cytotoxicity MOLT-4 ▪ PreB697 • and A549◊ to A) Alternariol monomethyl 
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Figure 4: Human fibroblast cell line cytotoxicity to endophytes A) EM-6 •, EM-7 □, EM-9 ◊; B) EL-14 ▪; 
C) Alternariol monomethyl ether (AME) and D) Alternariol (AOH).  Error bars represent the standard 







Figure 5: HPLC trace of endophytes A) EM-6, B) EM-7, C) EM-9, D) EL-14 in blue lines and 
standards alternariol monomethyl ether (AME) with retention time 13.9 minutes and 
alternariol (AOH) with retention time 11.2 minutes superimposed in black showing the 
presence of AME and AOH in EM-6, EM-7 and EM-9 and unidentified peaks in EM-6 at 
retention times of 9.1, 10.8 and 14.5 minutes and EL-14 at retention time of 14.5 minutes 
 
 
